FDA Approves First RAS-Targeted Drug for Pancreatic Cancer
FDA Approves First RAS-Targeted Drug for Pancreatic Cancer On August 26, 2026, the U.S. Food and Drug Administration granted approval
Read moreFDA Approves First RAS-Targeted Drug for Pancreatic Cancer On August 26, 2026, the U.S. Food and Drug Administration granted approval
Read moreDaniel Cressy, 23, became the first person in the Gulf South functionally cured of sickle cell disease using Casgevy gene therapy, while a new study finds younger generations are aging faster biologically, potentially explaining rising early-onset cancer rates. Combined with a 31-state foodborne outbreak and the worsening Bundibugyo virus crisis, here’s this week’s health roundup.
Read moreSponsored: This article is paid content from The Master Manifester. JACKSONVILLE, FL (PinionNewswire) — As manifestation continues to gain mainstream
Read more